Active project grants relating to our work in the Medicines Discovery Institute.

Project titleFunderAmount
Design and development of AMPA receptor modulators with a much improved safety profile as novel drugs for treating the cognitive dysfunction associated with schizophrenia and other CNS disordersWellcome Trust£4,100,000
α5-GABAA Receptor Modulators for the Treatment of Cognitive Impairment Associated with Huntington’s DiseaseWellcome Trust£3,200,000
LIMK1 inhibitors - A novel, disease-modifying approach for the treatment of fragile X syndromeMRC£2,440,000
MICA: Valium without sedation - Non-sedating anxiolytic GABAA receptor modulators for the treatment of anxiety disordersMRC£2,000,000
Integrating genetic, clinical and phenotypic data to advance stratification, prediction and treatment in mental healthMRC£900,000
Transforming Cardiff TranslationWellcome Trust£600,000
Mechanisms of aminoglyscoside ototoxicity and drug damage repair in sensory hair cells: Towards the design of otoprotective strategiesMRC£30,000